English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares
Jun 02, 2022 09:37 HKT
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares
Jun 01, 2022 12:08 HKT
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment
May 30, 2022 15:38 HKT
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region
May 24, 2022 08:21 HKT
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region
May 24, 2022 08:01 HKT
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region
May 24, 2022 07:40 HKT
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's fastest ageing region
May 24, 2022 06:00 HKT
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022
May 23, 2022 21:00 HKT
EC Healthcare Acquires Health Screening Services Chain, Further Expand Customer Base and Consolidate the Health Screening Market
May 23, 2022 19:51 HKT
Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit
May 20, 2022 11:10 HKT
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine
May 13, 2022 11:16 HKT
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022
May 12, 2022 09:00 HKT
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
May 12, 2022 06:00 HKT
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead(TM) Programs at the TIDES USA 2022
May 11, 2022 14:33 HKT
Novotech Acquires US CRO NCGS, Expands Global Expertise
May 05, 2022 09:00 HKT
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
May 05, 2022 04:05 HKT
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative
Apr 28, 2022 11:30 HKT
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Apr 27, 2022 16:09 HKT
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Apr 26, 2022 18:07 HKT
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Apr 24, 2022 17:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: